Literature DB >> 26916033

Adaptation and National Dissemination of a Brief, Evidence-Based, HIV Prevention Intervention for High-Risk Men Who Have Sex with Men.

Jeffrey H Herbst, Jerris L Raiford, Monique G Carry, Aisha L Wilkes, Renata D Ellington, David K Whittier.   

Abstract

CDC's high-impact human immunodeficiency virus (HIV) prevention approach calls for targeting the most cost-effective and scalable interventions to populations of greatest need to reduce HIV incidence. CDC has funded research to adapt and demonstrate the efficacy of Personalized Cognitive Counseling (PCC) as an HIV prevention intervention. Project ECHO, based in San Francisco, California, during 2010-2012, involved an adaptation of PCC for HIV-negative episodic substance-using men who have sex with men (SUMSM) and a randomized trial to test its efficacy in reducing sexual and substance-use risk behaviors. Episodic substance use is the use of substances recreationally and less than weekly. PCC is a 30-minute to 50-minute counseling session that involves addressing self-justifications men use for engaging in risky sexual behavior despite knowing the potential for HIV infection. By exploring these justifications, participants become aware of the ways they make sexual decisions, become better prepared to realistically assess their risk for HIV during future risky situations, and make decisions to decrease their HIV risk. The findings of Project ECHO demonstrated the efficacy of PCC for reducing HIV-related substance-use risk behaviors. The study also demonstrated efficacy of PCC for reducing sexual risk behaviors among SUMSM screened as nondependent on targeted drug substances. CDC has identified PCC as a "best evidence" HIV behavioral intervention and supports its national dissemination. Several features of PCC enhance its feasibility of implementation: it is brief, delivered with HIV testing, relatively inexpensive, allows flexibility in counselor qualifications and delivery settings, and is individualized to each client. The original PCC and its adapted versions can contribute to reducing HIV-related health disparities among high-risk MSM, including substance users, by raising awareness of and promoting reductions in personal risk behaviors.

Entities:  

Mesh:

Year:  2016        PMID: 26916033     DOI: 10.15585/mmwr.su6501a7

Source DB:  PubMed          Journal:  MMWR Suppl        ISSN: 2380-8942


  5 in total

1.  Self-Justifications for Unsafe Sex Among Incarcerated Young Men Who Have Sex with Men and Are Living with HIV: Results from a New York City Jail-Based Pilot Intervention.

Authors:  Janet J Wiersema; Anthony J Santella; Press Canady; Alison O Jordan
Journal:  J Community Health       Date:  2019-08

2.  Pathways from sexual stigma to incident HIV and sexually transmitted infections among Nigerian MSM.

Authors:  Cristina Rodriguez-Hart; Rebecca G Nowak; Rashelle Musci; Danielle German; Ifeanyi Orazulike; Blessing Kayode; Hongjie Liu; Oye Gureje; Trevor A Crowell; Stefan Baral; Man Charurat
Journal:  AIDS       Date:  2017-11-13       Impact factor: 4.177

3.  Characteristics of Sex Events, Partners, and Motivations and Their Associations with HIV-Risk Behavior in a Daily Diary Study of High-Risk Men Who Have Sex with Men (MSM).

Authors:  Tyler B Wray; Peter M Monti
Journal:  AIDS Behav       Date:  2020-06

4.  Unusual and unique distribution of anal high-risk human papillomavirus (HR-HPV) among men who have sex with men living in the Central African Republic.

Authors:  Ralph-Sydney Mboumba Bouassa; Marcel Mbeko Simaleko; Serge Police Camengo; Christian Diamant Mossoro-Kpinde; David Veyer; Mathieu Matta; Leman Robin; Jean De Dieu Longo; Gérard Grésenguet; Hélène Péré; Jean-François Meye; Laurent Belec
Journal:  PLoS One       Date:  2018-05-24       Impact factor: 3.240

5.  Personalized Cognitive Counseling Reduces Drinking Expectancy Among Men Who Have Sex with Men and Transgender Women in Lima, Peru: A Pilot Randomized Controlled Trial.

Authors:  R Colby Passaro; Susan Chávez-Gomez; Angelica Castañeda-Huaripata; Williams Gonzales-Saavedra; Matthew R Beymer; Eddy R Segura; Francisco Nanclares; James Dilley; Robinson Cabello; Jesse L Clark
Journal:  AIDS Behav       Date:  2020-11
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.